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Abstract
A total of 225 isolates of Salmonella enterica serovar Typhimurium from food-producing animals collected between
2003 and 2007 were examined for the prevalence of plasmid-mediated quinolone resistance (PMQR) determinants,
namely qnrA, qnrB, qnrC, qnrD, qnrS, qepA and aac(6’)Ib-cr, in Japan. Two isolates (0.8%) of S. Typhimurium DT104
from different dairy cows on a single farm in 2006 and 2007 were found to have qnrS1 on a plasmid of approxi-
mately 9.6-kbp. None of the S. Typhimurium isolates had qnrA, qnrB, qnrC, qnrD, qepA and acc(6’)-Ib-cr. Currently in
Japan, the prevalence of the PMQR genes among S. Typhimurium isolates from food animals may remain low or
restricted. The PFGE profile of two S. Typhimurium DT104 isolates without qnrS1 on the farm in 2005 had an identi-
cal PFGE profile to those of two S. Typhimurium DT104 isolates with qnrS1. The PFGE analysis suggested that the
already existing S. Typhimurium DT104 on the farm fortuitously acquired the qnrS1 plasmid.
Findings
Salmonella enterica serovar Typhimurium is prevalent
in many animal species [1-3] including food-producing
animals that are considered to be reservoirs for human
infection. S. Typhimurium was the top 5 serovar found
most frequently in cases of Salmonella foodborne illness
in Japan between 2006 and 2010 https://hasseidoko.
mhlw.go.jp/Byogentai/Pdf/data48e.pdf. Multidrug-resis-
tant S. Typhimurium definitive phage type 104 (DT104)
causes human salmonellosis in Japan [3]. S.T y p h i m u r -
ium DT104 was first isolated in the late 1980 s, and has
spread widely among food-producing animals across
Japan [3-5]. Although a decreased proportion of DT104-
related isolates among the animals was found between
2002 and 2005, multidrug-resistant S.T y p h i m u r i u m
remains prevalent among food-producing animals in
Japan [6].
In Japan, fluoroquinolone drugs were approved in veter-
inary fields in 1991 and are commonly used for treatment
of bacterial diseases such as enteritis and pneumonia in
food-producing animals [7]. In 2001, fluoroquinolone
resistance was found in S. Choleraesuis from pigs [8] and
S. Typhimurium from cattle [9]. In addition, a fluoroqui-
nolone-resistant S. Typhimurium was identified in bovine
isolates in 2005 [6]. The mechanism of fluoroquinolone
resistance in these isolates is the mutation of quinolone
resistance-determining regions (QRDRs) in DNA gyrase
and topoisomerase IV [8,9]. In 2006, qnrS1 was identified
in two S. Typhimurium isolates (including one DT104 iso-
late) from dairy cows and beef cattle, and S.T h o m p s o n
from poultry in Japan [10]. The report identified the
potential risk of foodborne infections of Salmonella con-
ferring the gene from food-producing animals to humans
in Japan.
Quinolone resistance mechanisms mediated by plas-
mids are responsible for target protection such as the
qnr genes, active efflux such as qepA, and enzymatic
modifications such as aac(6’)Ib-cr [11]. The plasmid-
mediated quinolone resistance (PMQR) genes contribute
* Correspondence: asai-t@nval.maff.go.jp
1National Veterinary Assay Laboratory, Ministry of Agriculture, Forestry and
Fisheries, 1-15-1 Tokura, Kokubunji, Tokyo 185-8511, Japan
Full list of author information is available at the end of the article
Asai et al. Gut Pathogens 2010, 2:17
http://www.gutpathogens.com/content/2/1/17
© 2010 Asai et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.to a reduction of quinolone susceptibility. In Japan, qnrS
was first identified in human isolates of Shigella flexneri
in 2003 [12]. qepA-harboring clinical isolates of Escheri-
chia coli were found in 2002 in Japan [13]. qnrB in
Klebsiella oxytoca, Pseudomonas mirabilis,a n dP. fluor-
escens,a n dqnrS in E. coli and Enterobacter cloacae
were found in zoo animal isolates in 2006 [14]. In addi-
tion, the presences of qnrS1 and qnrS2 in Salmonella
isolated from fecal samples of overseas travelers were
reported in Japan [15]. These reports provided an infec-
tious source of Enterobacteriaceae conferring plasmid-
mediated quinolone resistance in Japan. We examined
the prevalence of plasmid-mediated quinolone resistance
in S. Typhimurium isolated from food-producing
animals.
A total of 225 isolates of S. Typhimurium from food-
producing animals collected between 2003 and 2007
were derived from 156 cattle, 62 pigs and 7 poultry:
includes 42 isolates of DT104, 8 of DT104B, and 2 of
U302 (Table 1). Bacteriophage typing was performed
according to the methods of the Health Protection
Agency, London, United Kingdom [16]. Of the isolates,
132 S. Typhimurium isolates collected between 2003
and 2005 [6] were subjected to detection of the PMQR
genes. The remaining 93 isolates between 2006 and
2007 were investigated for the presence of the PMQR
genes and antimicrobial susceptibility. The presence of
qnrA, qnrB and qnrS genes was determined by PCR
[17]. The qnrC and qnrD genes were detected using the
primers as previously described [18,19], respectively.
The qepA and acc(6’)-Ib-cr genes were examined as pre-
viously described [20,21]. Nucleotide sequences of both
strands were determined directly on PCR products. The
DNA alignments and deduced amino acid sequences
were examined using the BLAST program (National
Center for Biotechnology Information, USA). Minimum
inhibitory concentrations (MICs) of antimicrobial agents
were determined using the agar dilution methods
according to the Clinical and Laboratory Standards
Institute (CLSI) guidelines [22]. The following 11 anti-
microbials were tested: ampicillin (ABPC), cefazolin,
colistin, chloramphenicol (CP), dihydrostreptomycin
(DSM), gentamicin, kanamycin, oxytetracycline (OTC),
nalidixic acid, enrofloxacin (ERFX), and trimethoprim.
The MICs of each antimicrobial agent were interpreted
using the recommendations of the CLSI [23]. The
breakpoints not seen in the CLSI were defined in a pre-
vious study [1]. Staphylococcus aureus ATCC 29213,
Enterococcus faecalis ATCC29212, E. coli ATCC 25922
and P. aeruginosa ATCC 27853 were used as quality
control strains.
Of 225 S. Typhimurium isolates, two isolates of
DT104, 18-PLS-16 and 19-PLS-45, from different dairy
c o w so nas i n g l ef a r mi n2 0 0 6a n d2 0 0 7s h o w e dqnrS
positive results. The sequencing of amplicons showed
complete identity to qnrS1 previously identified
on pAH0376 from a S. flexneri strain. None of the
S. Typhimurium isolates had qnrA, qnrB, qnrC, qnrD,
qepA and acc(6’)-Ib-cr. The two isolates exhibited ERFX
resistance (ERFX MIC, 2 mg/L) with resistances to
ABPC, DSM, OTC and CP (Table 2).
The QRDR of gyrA, parC and parE was examined in
ERFX-resistant isolates by PCR amplification and sequen-
cing using primers as described elsewhere [24]. In addition,
susceptibility of ERFX-resistant isolates to fluoroquinolones
was examined using the micro broth dilution methods
according to CLSI guidelines [22]. For evaluation of active
efflux of the ERFX-resistant bacteria, the MIC of ERFX
was determined by the agar dilution method in the pre-
sence of carbonyl cyanide m-chlorophenylhydrazone
(CCCP) (100 μM). They had no mutations in the QRDR of
GyrA, ParC and ParE. The MIC of ERFX was not changed
in the presence of CCCP (100 μM). The two isolates with
qnrS1 exhibited almost the same MIC observed for each
fluoroquinolone, which is relative low compared with the
MIC for isolate (17-PLS-75) with mutations in the QRDR
of GyrA and ParC.
Plasmid DNA was isolated from the qnrS1-positive
isolates by the alkaline lysis method [25]. Extracted
plasmids were transferred to Hybond-N+ membrane
(Amersham Biosciences, Buckinghamshire, UK) using
capillary blotting apparatus. The qnrS1 PCR product
was labeled with DIG-11-dUTP by PCR using a DIG
High Prime DNA Labeling Kit (Roche Diagnostics Ltd,
Table 1 Salmonella Typhimurium isolates used in this study
Cattle Pig Poultry
Isolation Phagetype Phagetype Phagetype
year Typhimurium 104 104B U302 Typhimurium 104 104B Typhimurium 104
2003 24 8 2 0 8 0 0 0 0
2004 25 3 0 2 8 1 0 0 0
2005 42 12 0 0 21 1 0 4 1
2006 23 4 0 0 11 2 0 2 1
2007 42 4 4 0 14 5 2 1 0
Total 156 31 6 2 62 9 2 7 2
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probe, hybridized DNA was detected using a DIG
Nucleic Acid Detection Kit (Roche Diagnostics Ltd).
Using a plasmid profiling test, an approximately 93-kbp
plasmid (virulence plasmid) was found in all four iso-
lates, whereas there was also an approximately 9.6-kbp
plasmid found in the qnr-conferring isolates. Hybridiza-
tion tests revealed that qnrS1 was located on the 9.6-
Kbp plasmid (Figure 1).
The appearance of S. Typhimurium DT104 conferring
qnrS1 on the farm is caused either by the introduction
of S. Typhimurium DT104 conferring qnrS1 or the
transfer of the qnrS1 plasmid to S. Typhimurium DT104
already existing on the farm. According to the CDC Pul-
seNet protocol [26], genetic relatedness of isolates were
analyzed by PFGE with XbaI and BlnI restriction
enzymes. The isolates tested included two qnrS1-nega-
tive isolates of S. Typhimurium DT104 isolated in 2005
on a farm in which qnrS1-conferring isolates were
found. In the present study, it was difficult to precisely
distinguish between the two S.T y p h i m u r i u mD T 1 0 4
isolates without qnrS1 and the two S. Typhimurium
DT104 isolates with qnrS1 by PFGE analysis (Figure 2).
Our previous study showed that there is a variation in
the BlnI-digested PFGE profiles of S.T y p h i m u r i u m
DT104 isolated from food-producing animals in Japan
[5]. These results suggested that the S. Typhimurium
DT104 already present on the farm fortuitously acquired
the qnrS1 plasmid. Previous studies showed that qnrS1
in Typhimurium isolated in the UK was present on plas-
mids of 10,066 bp, which were transferable by the con-
jugation test and carry an IncN replicon [27,28]. Further
study need to clarify the source of plasmid bearing
qnrS1.
Table 2 Susceptibility for several fluoroquinolones
Antimicrobials 18-PLS-16 19-PLS-45 17-PLS-75
Year isolated 2006 2007 2005
Sources Cattle Cattle Cattle
qnr qnrS1 qnrS1 -
mutation in gyrA WT WT S83F&D87N
mutation in parC WT WT S80R
phagetype 104 104 12
Naldixic acid 32 32 256
Oxolinic acid 4 4 >64
Flumequine 16 8 >64
Benofloxacin 4 4 16
Ciprofloxacin 1 1 8
Danofloxacin 2 2 16
Difloxacin 8 4 >32
Enrofloxacin 2 2 16
Levofloxacin 1 1 8
Norfloxacin 2 2 16
Figure 1 Plasmid profile of S. Typhimurium isolates on a farm.
Lane 1: 17-PLS-27, Lane 2: 17-PLS-28, Lane 3: 18-PLS-16, Lane 4: 19-
PLS-45, Lane 5: Super coiled DNA ladder.
Figure 2 PFGE profile of S. Typhimurium isolates on a farm.
Electrophoresis was performed using a CHEF-DR III System (Bio-Rad
Laboratories, Hercules, CA, USA) with running conditions of 1 phase
from 2.2 to 63.8 s at 180 V for 19 h. Lane1, 6, 11: Salmonella
Braenderup H9812 digested with XbaI. Lane 2 and 7: 17-PLS-27,
Lane 3 and 8: 17-PLS-28, Lane 4 and 9: 18-PLS-16, Lane 5 and 10:
19-PLS-45. Lane 2 to 5: XbaI digestion, Lane 7 to 10: BlnI digestion.
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Page 3 of 5This study demonstrated that the two isolates of
S. Typhimurium collected from different cattle on a
farm in 2006 and 2007 harbored qnrS1 on a 9.6-Kbp
plasmid. At present in Japan, dissemination of qnrS1
among S. Typhimurium isolates from food animals may
remain restricted. The spread of plasmids carrying
qnr among Salmonella isolates of animal origin could
have serious consequences for fluoroquinolone treat-
ment of non-typhoid Salmonella infection in humans
and animals. Previously, qnrS1 and qnrS2 were found in
serovars Typhimurium, Corvallis, Montevideo, Agona,
Braenderup and Alacua of Salmonella isolates from
fecal samples of overseas travelers who had visited Thai-
land, Malaysia, Vietnam, Indonesia and Singapore,
between 2001 and 2007 [15]. PMQR is identified in
human isolates of Enterobacteriaceae but is likely to be
rare in isolates from food-producing animals [29]. How-
ever, in China, plasmid-mediated quinolone resistance is
frequently found in the isolates from food-producing
animals [20]. Thus it would be difficult to prevent the
invasion of resistance genes from foreign countries to
Japan. The monitoring of fluoroquinolone use and qui-
nolone resistance in bacteria of food-producing animal
origin is essential to assess the level of risk of resistance
in food-borne bacteria in the animals.
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